Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Journal of Hypertension|February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthaseAino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE<sup>-/-</sup> miceNordin M J Hanssen, Chris Tikellis, Raelene J Pickering, et al.
Kidney International|May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathySally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetologia|May 7, 2020
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetesCindy Gueguen, Sandra L Burke, Benjamin Barzel, et al.
Diabetes|February 17, 2018
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to ApoptosisShinji Hagiwara, Karly Sourris, Mark Ziemann, et al.
The Journal of Clinical Investigation|December 12, 2018
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesisRaelene J Pickering, Christos Tikellis, Carlos J Rosado, et al.
Kidney International|March 18, 2011
Targeted reduction of advanced glycation improves renal function in obesityBrooke E Harcourt, Karly C Sourris, Melinda T Coughlan, et al.
Circulation Research|June 23, 2020
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting MyelopoiesisMichelle C Flynn, Michael J Kraakman, Christos Tikellis, et al.
The Journal of Clinical Investigation|January 12, 2023
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetesIshant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Journal of Hypertension|February 27, 2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthaseAino Soro-Paavonen, Wei-Zeng Zhang, Kylie Venardos, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 14, 2023
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE<sup>-/-</sup> miceNordin M J Hanssen, Chris Tikellis, Raelene J Pickering, et al.
Kidney International|May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathySally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Diabetologia|May 7, 2020
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetesCindy Gueguen, Sandra L Burke, Benjamin Barzel, et al.
Diabetes|February 17, 2018
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to ApoptosisShinji Hagiwara, Karly Sourris, Mark Ziemann, et al.
The Journal of Clinical Investigation|December 12, 2018
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesisRaelene J Pickering, Christos Tikellis, Carlos J Rosado, et al.
Kidney International|March 18, 2011
Targeted reduction of advanced glycation improves renal function in obesityBrooke E Harcourt, Karly C Sourris, Melinda T Coughlan, et al.
Circulation Research|June 23, 2020
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting MyelopoiesisMichelle C Flynn, Michael J Kraakman, Christos Tikellis, et al.
The Journal of Clinical Investigation|January 12, 2023
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetesIshant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, et al.
Pageof 18